Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e1a3e42b725275d681dd5460bb454c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed3488270fb0d22530bc61db8770cfa6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
filingDate |
2005-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa266c22a95c57eac5232a9a83375c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b66a8b1a855f728b6c8525784fb61c7 |
publicationDate |
2006-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006079463-A1 |
titleOfInvention |
Anticancer compositions comprising methenamine |
abstract |
The invention is directed to anti-cancer compositions comprising methenamine or its derivatives or conjugates, and to use of such methenamine containing compositions to treat cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012145981-A1 |
priorityDate |
2003-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |